Financhill
Back

Vertex Pharmaceuticals 10K Form

Buy
64

VRTX
Vertex Pharmaceuticals

Last Price:
432.79
Seasonality Move:
7.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive VRTX News And Ratings

See the #1 stock for the next 7 days that we like better than VRTX

VRTX Financial Statistics

Sales & Book Value

Annual Sales: $9.87B
Cash Flow: $118.5M
Price / Cash Flow: 34.38
Annual Sales: $68.22
Price / Book: 6.36

Profitability

EPS (TTM): 13.89000
Net Income (TTM): $3.62B
Gross Margin: $8.61B
Return on Equity: 23.23%
Return on Assets: 17.76%

Vertex Pharmaceuticals Earnings Forecast

Key Vertex Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 33 years for VRTX is 87.21%.
  • The Selling, General & Administrative Expenses for VRTX have been equal to 11.52% of Gross Profit Margin.
  • The Research & Development expenses have been 32.05% of Revenue.
  • The Interest Expense is 1.22% of Operating Income.
  • The Net Earning history of VRTX is 36.68% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 14 years.

Vertex Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Healthcare
Current Symbol: VRTX
CUSIP: 92532F
Website: vrtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.99
Quick Ratio: 3.6

Price-to-Earnings

Trailing P/E Ratio: 31.16
Forward P/E Ratio: 23.57

VRTX Technical Analysis vs Fundamental Analysis

Buy
64
Vertex Pharmaceuticals (VRTX) is a Buy

Is Vertex Pharmaceuticals a Buy or a Sell?